Expression of the Short Form of RON/STK in Feline Mammary Carcinoma

Lorella Maniscalco1, Silvia Guil-Luna2,3, Selina Iussich1

  • 11 Department of Veterinary Sciences, University of Turin, Grugliasco, Italy.

Veterinary Pathology
|December 19, 2018
PubMed

Insights

Researchers studied feline mammary carcinoma (FMC) and found the short form of RON (sf-RON) is expressed in tumors. sf-RON presence indicates a poorer prognosis, supporting FMC as a comparative oncology model.

Area of Science:

  • Oncology
  • Molecular Biology
  • Veterinary Medicine

Background:

  • The RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein (MSP), are implicated in human breast cancer progression.
  • The short form of RON (sf-RON) arises from an alternative promoter and plays a role in human breast cancer.
  • Feline mammary carcinoma (FMC) shares similarities with human breast cancer, making it a valuable model for comparative studies.

Purpose of the Study:

  • To investigate the expression of RON and MSP in feline mammary tumors.
  • To identify the presence and origin of the sf-RON transcript in FMCs.
  • To evaluate the association of sf-RON expression with tumor characteristics and patient outcomes.

Main Methods:

  • Immunohistochemistry was used to detect RON and MSP expression in 50 FMCs and 10 benign lesions.
  • RNA was extracted from paraffin-embedded tissues for RT-PCR analysis to identify sf-RON transcripts.
  • Statistical analysis, including hazard ratios, was performed to assess the impact of sf-RON on disease-free period and survival.

Main Results:

  • RON and MSP expression was detected in 68% and 58% of FMCs, respectively.
  • The sf-RON transcript was identified in 38% of FMCs, originating from an alternative promoter (P2) as seen in humans.
  • sf-RON expression correlated with poorly differentiated tumors, shorter disease-free periods (HR, 2.2), and reduced survival (HR, 2.2).

Conclusions:

  • Feline mammary carcinoma serves as a relevant model for comparative oncology research.
  • The expression of sf-RON in FMCs is linked to adverse prognostic factors.
  • sf-RON may serve as a potential predictive biomarker for outcomes in feline mammary carcinoma.

Related Concept Videos

The Mammary Glands01:12

The Mammary Glands

The female breast is a hemispheric projection of variable size positioned anterior to the pectoralis major and serratus anterior muscles. A fascia layer composed of dense, irregular connective tissue connects it to these muscles.
Each breast features a pigmented projection known as the nipple, through which milk emerges via closely spaced openings of ducts, referred to as lactiferous ducts. Surrounding the nipple is a circular pigmented area of skin named the areola, which appears rough due to...
2.2K
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
24.8K
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
6.6K